Clen-Max
Manufacturer – Maxtreme Pharma
Drug form – 100 tablets at 40 micrograms
Active ingredient – Clenbuterol hydrochloride
In bodybuilding, there are quite often cases when initially medical drugs are used for sports purposes and, in terms of their effect, are much better than classical drugs. And among the most striking examples, Clenbuterol is distinguished, which served to treat asthma, but also serves for active fat burning.
Fact: When it enters the body, all the active ingredients in the composition begin to actively use not carbohydrates as an energy source, but fat deposits. And this is what contributes to weight loss and muscle drying.
Beneficial features
This product from the manufacturer Maxtreme Pharma provides some properties:
Acceleration of metabolism by 20-30%.
Reduces the risk of fat accumulation in the body during the intake.
Stimulates the hormonal system, which is involved in fat burning.
Muscles get rid of excess fat and receive definition.
But these qualities are fully manifested only with strict adherence to diet, exercise and sleep.
There is a ton of misleading information on the Internet regarding anabolic effects. This myth is due to the fact that earlier experiments were carried out on animals in high dosages, up to 1000mcg. For humans, this dose will be lethal, while the recommended dose does not produce an anabolic effect.
Side effects
This drug is considered one of the safest to use, but there are a number of side effects here:
Nausea.
Increased heart rate.
Diarrhea.
Increased pressure.
Sleep disturbance.
Increased sweating.
Feeling anxious.
Convulsions, sometimes tremors in the body
But most often, some of these problems are solved independently, without intervention, in other cases thanks to additional means. It is only important to comply with the recommended dose and use drugs, and of course, follow a strict diet.
Tip: The main task of Clenbuterol is to burn fat. If the goal is to achieve other results, then it is advisable to purchase steroids.






Reviews
There are no reviews yet.